Apostol, George
Novartis (Switzerland)
2 papers on CoChatORCID 0009-0009-5456-6142
Most cited papers
- Verified
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 336
- Verified
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
Berry-Kravis, E., Des Portes, V., Hagerman, R., Jacquemont, S., Charles, P., Visootsak, J., Brinkman, M., Rerat, K., Koumaras, B., Zhu, L., et al. (2016) · Science Translational Medicine
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 270
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free